Skin cancers in skin of color
George Cohen, MD, with John Jesitus Identifying skin cancers including melanoma in patients with skin of color (SOC) requires dispelling misconceptions, addressing healthcare disparities, and performing careful examinations. It is a misconception that skin cancer does not occur in non-Caucasian patients. Being black does not make one immune to skin cancer. But it does make […]
The New Neurotoxin Dosing Paradigm
Dr. Michael Gold discusses how the expected approval for long-lasting newcomer, DAXI, is pushing the envelope for current FDA-approved neurotoxins to examine higher doses. “DAXI is changing a lot of things in the in the toxin space,” says Michael Gold, MD, FAAD. “DAXI will get an approval, most likely, for the longest acting toxin that […]